Accounts Submission


HUBNER ONCOLOGY LIMITED

Company Registration Number:
08392821 (England and Wales)

Unaudited micro entity accounts for the year ended 28 February 2022

Period of accounts

Start date: 01 March 2021

End date: 28 February 2022

HUBNER ONCOLOGY LIMITED

Contents of the Financial Statements

for the Period Ended 28 February 2022

Company Information - 3
Balance sheet - 4
Footnotes to the Balance Sheet - 6

HUBNER ONCOLOGY LIMITED

Company Information

for the Period Ended 28 February 2022




Director: R Hubner
Registered office: 53
The Market
Rose Hill
Sutton
Surrey
SM1 3HE
Company Registration Number: 08392821 (England and Wales)

HUBNER ONCOLOGY LIMITED

Balance sheet

As at 28 February 2022


2022
£

2021
£
Fixed Assets: 2 2
Current assets: 103,766 76,865
Creditors: amounts falling due within one year: ( 33,988 ) ( 28,455 )
Net current assets (liabilities): 69,778 48,410
Total assets less current liabilities: 69,780 48,412
Total net assets (liabilities): 69,780 48,412
Capital and reserves: 69,780 48,412

HUBNER ONCOLOGY LIMITED

Balance sheet continued

For the year ending 28 February 2022 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 14 November 2022
And Signed On Behalf Of The Board By:

Name: R Hubner
Status: Director

The notes form part of these financial statements

HUBNER ONCOLOGY LIMITED

Footnotes to the Financial Statements

for the Period Ended 28 February 2022

  • 1. Employee Information

    Average number of employees: 2

HUBNER ONCOLOGY LIMITED

Footnotes to the Financial Statements

for the Period Ended 28 February 2022

  • 2. Off balance sheet disclosure

    No